Danilo Abbati

Milan, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

T cells dressed up with a dual HLA-restricted TCR targeting cathepsin G drive effective AML eradication.

T cells dressed up with a dual HLA-restricted TCR targeting cathepsin G drive effective AML eradication.

Journal: Blood
Published: July 07, 2025

T cells dressed up with a dual HLA-restricted TCR targeting cathepsin G drive effective AML eradication.

T cells dressed up with a dual HLA-restricted TCR targeting cathepsin G drive effective AML eradication.

Journal: Blood
Published: July 07, 2025

TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength.

TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength.

Journal: Nature communications
Published: April 15, 2025

The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients' survival and long COVID.

The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients' survival and long COVID.

Journal: Frontiers in immunology
Published: February 02, 2024

Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR.

Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR.

Journal: Science advances
Published: December 01, 2023

TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells.

TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells.

Journal: Frontiers in immunology
Published: October 10, 2023

Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells.

Epithelial ovarian cancer is infiltrated by activated effector T cells co-expressing CD39, PD-1, TIM-3, CD137 and interacting with cancer cells and myeloid cells.

Journal: Frontiers in immunology
Published: April 26, 2023

Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo.

Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo.

Journal: Gut
Published: July 29, 2022

Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells.

Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells.

Journal: Gut
Published: June 14, 2022

Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on cytomegalovirus reactivation risk after allogeneic hematopoietic stem cell transplantation.

Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on cytomegalovirus reactivation risk after allogeneic hematopoietic stem cell transplantation.

Journal: Haematologica
Published: January 18, 2022

Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases.

Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases.

Journal: Life science alliance
Published: November 24, 2021

Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cells.

Flow cytometry data mining by cytoChain identifies determinants of exhaustion and stemness in TCR-engineered T cells.

Journal: European journal of immunology
Published: December 03, 2020
Showing 1-12 of 12

Last Updated: 09/26/2026